Genentech is committed to supporting programs open to a broad audience that benefit patients, the scientific or medical community, and/or public health.
Genentech is committed to supporting our existing grantees during the evolving coronavirus (COVID-19) pandemic. We understand that grantees will have their own challenges in adapting to rapidly changing events, and we will work to accommodate needs for the programs funded by Genentech.
If you are an existing grantee, please contact your Genentech representative with questions or to let us know if your program or event will be cancelled or postponed. If you are unsure of who to contact, please email [email protected] and we will direct you to the appropriate person.
Scientific Project Support provides funding for general research, translational research, other research or development projects, and/or other initiatives of research organizations, labs, and academic institutions. Research collaborations, clinical trials and associated correlative research involving or undertaken in relation to Genentech or Roche products (whether investigational and/or approved for other uses) are excluded from this type of support. For information regarding these types of programs refer to our pipeline.
The mission of Genentech's development program is to provide funding to foster training and research that supports Genentech therapeutic areas. Genentech/Roche supports general research, investigator, development and research awards, and other research projects that have a scientific basis.
Grant requests must be submitted at least 60 days prior to the project/program start date. The following uploads are required to submit your application:
Funding Request System Resources
Learn more about the funding request process.
Operating expenses must be directly and exclusively dedicated to the activity for which the requestor is applying.
Genentech/Roche will consider funding requests in the following disease states:
In order to be eligible for this type of funding, your organization must not be:
In order to be eligible for this type of funding, the funding must not be used for:
Indirect costs cannot exceed more than 25% of the charitable grant amount.
The scientific project must not have commenced prior to the approval for funding.
Researchers assigned to the research project must be qualified (e.g., not subject to medical license suspension or revocation, not debarred or disqualified by a federal or state agency).
An organization with a written policy to discriminate based on race, religion, gender, gender expression and/or identity, age, national origin, disability, marital status, sexual orientation, military status, or any other protected status is ineligible for funding.
Genentech has a rolling review policy when evaluating funding requests for scientific project support. This allows qualified requestors the opportunity to apply anytime during year.
Requests must be submitted at least 60 days prior to the project/program start date. Decisions are made on a case-by-case basis; you will usually hear back from Genentech prior to the project/program start date.
All grants must abide by the terms in the Genentech Letter of Agreement (LOA), which is issued to an authorized signer of your organization once the application is approved. You must agree to the terms of the LOA before any funding is issued. If you have any questions on the agreement terms, please contact us at (877) 313-5778.
Note: The funding application site does not support IE8 or earlier
We support investigators in academia by supplying key reagents. Request proteins, antibodies, and cDNAs.